Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena I Kovalenko

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Histochemistry and Cell Biology|January 18, 2007
Clustered carbohydrates as a target for natural killer cells: a model systemElena I Kovalenko, Elena Abakushina, William Telford, et al.
Immune Network|May 11, 2026
In Search of Adaptive-Like Features of NK Cells Co-Expressing NKG2C and NKG2ANadezhda A Alekseeva, Maria O Ustiuzhanina, Julia D Vavilova, et al.
Cell Death Discovery|June 12, 2026
Interplay of telomerase non-canonical functions in NK cell resistance to iCasp9-mediated apoptosisAnastasia I Palamarchuk, Maria O Ustiuzhanina, Rodion A Velichinskii, et al.
Cytotherapy|September 13, 2025
PSCA-CAR-NK cells exert cytotoxic activity against PSCA-expressing tumor cells and are characterized by a specific chemokine profileRodion A Velichinskii, Maria A Streltsova, Julia D Vavilova, et al.
Journal of Leukocyte Biology|September 15, 2020
CD56<sup>dim</sup> CD57<sup>-</sup> NKG2C<sup>+</sup> NK cells retaining proliferative potential are possible precursors of CD57<sup>+</sup> NKG2C<sup>+</sup> memory-like NK cellsPolina A Kobyzeva, Maria A Streltsova, Sofya A Erokhina, et al.
Plos One|December 6, 2018
Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2AMaria A Streltsova, Sofya A Erokhina, Leonid M Kanevskiy, et al.
Frontiers in Immunology|May 20, 2021
HLA-DR-Positive NK Cells Expand in Response to Mycobacterium Tuberculosis Antigens and Mediate Mycobacteria-Induced T Cell ActivationSofya A Kust, Maria A Streltsova, Alexander V Panteleev, et al.
Nanotechnology|January 6, 2015
Towards hybrid biocompatible magnetic rHuman serum albumin-based nanoparticles: use of ultra-small (CeLn)3/4+ cation-doped maghemite nanoparticles as functional shellLiron L Israel, Elena I Kovalenko, Anna A Boyko, et al.
Frontiers in Immunology|March 5, 2021
Surface NKG2C Identifies Differentiated αβT-Cell Clones Expanded in Peripheral BloodElena I Kovalenko, Ivan V Zvyagin, Maria A Streltsova, et al.
International Journal of Molecular Sciences|January 24, 2019
Recurrent Stimulation of Natural Killer Cell Clones with K562 Expressing Membrane-Bound Interleukin-21 Affects Their Phenotype, Interferon-γ Production, and LifespanMaria A Streltsova, Sofya A Erokhina, Leonid M Kanevskiy, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Histochemistry and Cell Biology|January 18, 2007
Clustered carbohydrates as a target for natural killer cells: a model systemElena I Kovalenko, Elena Abakushina, William Telford, et al.
Immune Network|May 11, 2026
In Search of Adaptive-Like Features of NK Cells Co-Expressing NKG2C and NKG2ANadezhda A Alekseeva, Maria O Ustiuzhanina, Julia D Vavilova, et al.
Cell Death Discovery|June 12, 2026
Interplay of telomerase non-canonical functions in NK cell resistance to iCasp9-mediated apoptosisAnastasia I Palamarchuk, Maria O Ustiuzhanina, Rodion A Velichinskii, et al.
Cytotherapy|September 13, 2025
PSCA-CAR-NK cells exert cytotoxic activity against PSCA-expressing tumor cells and are characterized by a specific chemokine profileRodion A Velichinskii, Maria A Streltsova, Julia D Vavilova, et al.
Journal of Leukocyte Biology|September 15, 2020
CD56<sup>dim</sup> CD57<sup>-</sup> NKG2C<sup>+</sup> NK cells retaining proliferative potential are possible precursors of CD57<sup>+</sup> NKG2C<sup>+</sup> memory-like NK cellsPolina A Kobyzeva, Maria A Streltsova, Sofya A Erokhina, et al.
Plos One|December 6, 2018
Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2AMaria A Streltsova, Sofya A Erokhina, Leonid M Kanevskiy, et al.
Frontiers in Immunology|May 20, 2021
HLA-DR-Positive NK Cells Expand in Response to Mycobacterium Tuberculosis Antigens and Mediate Mycobacteria-Induced T Cell ActivationSofya A Kust, Maria A Streltsova, Alexander V Panteleev, et al.
Nanotechnology|January 6, 2015
Towards hybrid biocompatible magnetic rHuman serum albumin-based nanoparticles: use of ultra-small (CeLn)3/4+ cation-doped maghemite nanoparticles as functional shellLiron L Israel, Elena I Kovalenko, Anna A Boyko, et al.
Frontiers in Immunology|March 5, 2021
Surface NKG2C Identifies Differentiated αβT-Cell Clones Expanded in Peripheral BloodElena I Kovalenko, Ivan V Zvyagin, Maria A Streltsova, et al.
International Journal of Molecular Sciences|January 24, 2019
Recurrent Stimulation of Natural Killer Cell Clones with K562 Expressing Membrane-Bound Interleukin-21 Affects Their Phenotype, Interferon-γ Production, and LifespanMaria A Streltsova, Sofya A Erokhina, Leonid M Kanevskiy, et al.
Pageof 5